Table 1 The characteristics of SCLC patients and healthy controls
From: Prognostic significance of serum osteopontin levels in small cell lung cancer
Variables | SCLC patients | Healthy controls | P |
|---|---|---|---|
Number of subject | 96 | 60 | |
Median (range) | 55 (36–75) | 56 (38–74) | 0.618 |
Male/Female | 66/30 | 40/20 | 0.786 |
Smoking history | |||
Ever smoker | 58 | 32 | 0.384 |
Never smoker | 38 | 28 | |
Performance status | |||
0–1 | 56 | ||
2–3 | 40 | ||
Disease stage | |||
Limited | 28 | ||
Extended | 58 | ||
Tumor size (cm) | |||
≥ 3 | 76 | ||
< 3 | 20 | ||
Lymph node metastasis | |||
N0 | 26 | ||
N1–3 | 70 | ||
Chemotherapy | |||
EP | 80 | ||
EC | 16 | ||
Radiotherapy sequence | |||
Concurrent | 43 | ||
After-chemotherapy | 40 | ||
None | 13 | ||
Responses | |||
CR + PR | 78 | ||
SD + PD | 18 | ||